Cost-Effectiveness of Adjuvant Abemaciclib and Ribociclib in High-Risk Hormone Receptor–Positive Early Breast Cancer: An Indian Perspective
Article in JCO Global Oncology (July 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in JCO Global Oncology (July 2024)
Article in Quantitative Imaging in Medicine and Surgery (July 2024)
Article in Breast Cancer Research and Treatment (May 2024)